10-K: Surgery Partners, Inc. Reports Full Year 2023 Results in 10-K Filing

Surgery Partners, Inc. reports an 8% increase in revenue and a net loss of $11.9 million for the full year 2023, according to its 10-K filing.

Summary

• Surgery Partners, Inc. reported a revenue increase of 8% to $2.7 billion for the full year 2023, compared to $2.5 billion in 2022.
• The company's net loss attributable to common stockholders was $11.9 million for 2023, an improvement from a $54.6 million loss in 2022.
• Adjusted EBITDA increased by 15.2% to $438.1 million in 2023, up from $380.2 million in the previous year.
• The Surgical Facility Services segment contributed approximately 98% of the total revenue in 2023.
• The company operated 162 surgical facilities, including 144 ASCs and 18 surgical hospitals, across 33 states as of December 31, 2023.
• Patient services in ASCs and surgical hospitals generated approximately $2.6 billion in revenue during 2023.
• The company estimates the total U.S. outpatient surgical facility market to be greater than $90 billion in annual revenue.
• The company estimates that approximately $60 billion of inpatient surgical cases have the potential to move to outpatient surgery centers.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue and profitability, but also highlights risks and challenges. The overall sentiment is cautiously optimistic.

Positives

• The company experienced significant revenue growth, indicating strong demand for its services.
• The increase in Adjusted EBITDA suggests improved operational efficiency and cost management.
• The reduction in net loss demonstrates progress towards profitability.
• The company's strategic acquisitions and development activities are expanding its market presence.
• The company has a strong cash position and available borrowing capacity.

Negatives

• The company still reported a net loss for the year, despite improvements.
• The company's operations are subject to various risks, including regulatory changes and competition.
• The company has a significant amount of debt, which could impact its financial flexibility.
• The company's operations are sensitive to regulatory, economic and other conditions in the states where they are located, particularly Texas and Idaho.

Risks

• The company is dependent on payments from third-party payors, including government health care programs and private insurance organizations, which are subject to change.
• The company's ability to maintain relationships with physicians and attract new physician partners is crucial for its success.
• The company faces competition from other health care facilities and providers.
• The company is subject to numerous federal and state laws and regulations, and failure to comply could result in penalties.
• Cybersecurity attacks or intrusions could adversely impact the company's business.
• The company's leverage could adversely affect its ability to raise additional capital and react to changes in the economy or industry.

Future Outlook

The company believes favorable industry trends such as an aging population, advancements in medical technology and payor and government encouragement to move high acuity procedures from acute care to lower cost sites of care will further drive growth. The company also plans to continue its disciplined acquisition strategy and seek strategic relationship opportunities with health care systems.

Management Comments

• The company is focused on improving same-facility performance, selectively acquiring established facilities, developing new facilities and other portfolio management initiatives.
• The company's differentiated operating model employs a multifaceted strategy to grow revenue, earnings and cash flow.

Industry Context

The company operates in the competitive healthcare services industry, facing competition from hospitals, other surgical facilities, and physician groups. The trend of moving procedures to outpatient settings is expected to benefit the company, but it also faces challenges from cost containment efforts by payors and regulatory changes.

Comparison to Industry Standards

• The company competes with large national companies such as HCA Healthcare, Inc., AMSURG Corp., Tenet Healthcare Corporation and Optum, Inc., as well as local hospitals and other providers.
• The company's growth strategy includes acquisitions and development of new facilities, which is a common approach in the industry.
• The company's focus on outpatient surgical facilities aligns with the industry trend of shifting procedures from inpatient to outpatient settings.
• The company's financial performance is compared to industry benchmarks, such as revenue growth, EBITDA margins, and same-facility growth.

Related Party Transactions

• The company had operating lease agreements with physician investors who are related parties.
• The company paid rent under finance lease agreements with physician investors and a lessor who are related parties.

Stakeholder Impact

• Shareholders will be impacted by the company's financial performance and strategic decisions.
• Employees will be impacted by the company's compensation and benefit programs.
• Patients will be impacted by the quality and accessibility of the company's services.
• Physicians will be impacted by the company's partnership and operating agreements.

Next Steps

• The company will continue to focus on improving same-facility performance.
• The company will continue to selectively acquire established facilities.
• The company will continue to develop new facilities.
• The company will continue to pursue other portfolio management initiatives.

Key Dates

Keywords

surgical facilities, ambulatory surgery centers, healthcare services, physician practices, outpatient surgery, revenue growth, EBITDA, acquisitions, financial results, Medicare, Medicaid